Aquestive Therapeutics, Inc. (AQST)
Latest AQST Insider Trades
About Aquestive Therapeutics, Inc. (AQST)
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
- WARREN, NJ
- 147
- 2018
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 100,000 | $437K |
| Grant or award | 6 | 303,000 | |
| Option exercise | 2 | 50,000 |
AQST Insider Transactions (Form 4)
3952 Form 4 filings on record, the earliest from Nov 27, 2024, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Melina Cioffi - Officer | Grant or award | Non-Qualified Stock Option (right to buy) | 75,000 |
Recent AQST Form 8-K Filings
5Recent AQST Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Daniel Barber | Officer | 25,000 | $106K | View on EDGAR | |
| - | - |
AQST Insider Trading - FAQ
What is the latest insider trade for AQST?
Aquestive Therapeutics, Inc. (AQST) had 12 insider filings in the last 90 days, with the most recent on 2026-08-18. The full record for AQST runs to 52 Form 4 filings, the earliest from 2024-11-27. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying AQST stock?
No insider purchases of AQST were filed in the last 90 days.
How many insiders are selling AQST stock?
5 insider sales of AQST were filed in the last 90 days, totaling $437K.
Where can I see AQST SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks AQST Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow AQST insider buys?
Create a free InsiderAlpha account and press Watch on this page to add AQST to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Daniel Barber view on EDGAR
- - Sherry Korczynski view on EDGAR
- - Daniel Barber view on EDGAR
- - Julie Krop view on EDGAR
- - Daniel Barber view on EDGAR
- - Timothy E. Morris view on EDGAR
- - Julie Krop view on EDGAR
- - Abigail L. Jenkins view on EDGAR
- - John Cochran view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where AQST's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track AQST insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.